Equity

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Glaxosmithkline Pharmaceuticals LtdIndustry : Pharmaceuticals - Multinational
BSE Code:500660 P/E (TTM) :42.94
ISIN Demat:INE159A01016 Div & Yield %:2.25 EPS (TTM) :55.87
Book Value (RS) :100.5174369 Market Cap (Rs Cr.):40637.97 Face Value (RS) :10
    Change Company 
Particulars Quarter Ended
(Sep 2025)
Quarter Ended
(Sep 2024)
Quarter Ended
(% Var)
Sales 973.63 1,000.05 -2.64
Other Income 33.91 36.88 -8.05
PBIDT 368.59 355.83 3.59
Interest 0.51 0.27 88.89
PBDT 368.08 355.56 3.52
Depreciation 17.43 16.86 3.38
PBT 350.65 338.70 3.53
Tax 95.21 97.46 -2.31
Deferred Tax 0.44 -7.45 0.00
PAT 255.00 248.69 2.54

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)